News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

West Virginia AG Blasts "Irresponsible, Sweetheart" EpiPen Settlement With Mylan (MYL)



11/4/2016 7:10:55 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
There's no home court advantage for Mylan when it comes to the EpiPen controversy.

West Virginia's attorney general Wednesday called on the Justice Department to reject an announced $465 million settlement from Mylan to resolve allegations that the big pharma company shortchanged the Medicaid system in rebates for sales of the anti-allergy device EpiPen.

AG Patrick Morrisey called that yet-to-be-signed settlement announced last month a "sweetheart deal" that is "irresponsible," "woefully deficient," and "not in the best interests of West Virginia" if the amount Mylan has said it will pay is correct.

Read at CNBC


comments powered by Disqus
CNBC
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES